Payal Agrawal Divakaran: Kathryn Taylor Reddy and I share our view on the importance of timing
Hil Moss, Co-Founder and CEO of OncoveryCare, shared a post by Partner at .406 Ventures, on LinkedIn:
“Grateful to Payal Agrawal Divakaran, Kathryn Taylor Reddy, and the team at. 406 Ventures for such a thoughtful analysis of the need for a new model for cancer survivorship care—for stakeholders across the healthcare ecosystem (starting, of course, with survivors ourselves). Onward!”
Quoting ‘s post:
“Years in the making, Kathryn Taylor Reddy and I describe the investment thesis around OncoveryCare below. In this piece, we share our view on the importance of timing — not only is it the right time for a new model of cancer survivorship care, but it was definitely worth waiting to partner with Hil Moss, Justin Grischkan, Natalie Dickson, and Stephen Schleicher!”
Read further.
Source: Hil Moss/LinkedIn and /LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023